
Thomas Kirkegaard Jensen is no longer a part of the biotech company he helped found more than a decade ago, he informs MedWatch.
For the past 12 years, Kirkegaard Jensen has served as chief scientific officer at Orphazyme, a position from which he has now been let go, he says, which the company’s CEO, Anders Vadsholt, confirms.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app